PD35-10 EVEROLIMUS FOR RENAL ANGIOMYOLIPOMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX: EFFICACY AND SAFETY AFTER 3.5 YEARS OF TREATMENT IN THE EXIST-2 STUDY-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD35-10 EVEROLIMUS FOR RENAL ANGIOMYOLIPOMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX: EFFICACY AND SAFETY AFTER 3.5 YEARS OF TREATMENT IN THE EXIST-2 STUDY

Published:2015-04 Issue:4S Volume:193 Page:
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Bissler John¹,Kingswood J.²,Radzikowska Elzbieta³,Zonnenberg Bernard⁴,Frost Michael⁵,Belousova Elena⁶,Sauter Matthias⁷,Nonomura Norio⁸,Brakemeier Susanne⁹,de Vries Petrus¹⁰,Berkowitz Noah¹¹,Peyrard Severine¹²,Budde Klemens⁹

Affiliation:

1. Memphis, TN

2. Brighton, United Kingdom

3. Warsaw, Poland

4. Utrecht, Netherlands

5. St. Paul, MN

6. Moscow, Russian Federation

7. Munich, Germany

8. Osaka, Japan

9. Berlin, Germany

10. Cape Town, South Africa

11. East Hanover, NJ

12. Rueil-Malmaison, France

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Avances en uro-oncología «OncoForum»: lo mejor de 2015;Actas Urológicas Españolas;2016-07

2. Developments in urologic oncology “OncoForum”: The best of 2015;Actas Urológicas Españolas (English Edition);2016-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP